Levin Klaus, Madsen Jette R, Petersen Inge, Wanscher Christina E, Hangaard Joergen
Department of Endocrinology, Odense University Hospital, Svendborg, Denmark.
J Diabetes Sci Technol. 2013 May 1;7(3):587-95. doi: 10.1177/193229681300700302.
The increasing number of patients with diabetes poses a major challenge for the health care system. One instrument to meet these challenges could be the use of telemedicine, which, at the same time, may reduce treatment costs. Since 2005, diabetes patients on the island of Aeroe have been offered expert diabetes care using teleconsultations. This article describes the impact of the telemedicine solution on essential diabetes treatment parameters, patient satisfaction, and cost-effectiveness.
Telemedicine consultations were conducted with the patient and nurse specialist placed in a consultation room of Aeroe Hospital in audiovisual contact with the physician situated at the hospital on the mainland. Consultations were supported by an electronic patient record and a Web-based quality-monitoring diabetes database.
Inclusion criteria in this retrospective study were at least 6 months of telemedicine diabetes control with a minimum of two visits and two hemoglobin A1c (HbA1c) values. Results were compared with data from the Danish National Diabetes Registry (DVDD). Data are given in medians. In total, 23 type 1 diabetes mellitus (T1DM) patients, aged 65 (56-74) versus 48 years, diabetes duration 21.0 (10.7-31.3) versus 20.5 years, and 55 type 2 diabetes mellitus (T2DM) patients, aged 67 (64-70) versus 65 years, diabetes duration 14.0 (10.5-17.5) versus 11.7 years, were included. After teleconsultation, HbA1c in T1DM patients was 8.0% (7.4-8.6%) versus 7.9% [64 (57-71) versus 63 mmol/mol], not significant, and in T2DM patients was 7.4% (7.1-7.7%) versus 7.6% [57 (54-61) versus 60 mmol/mol], p < .05. Body mass index, blood pressure, and lipid values were comparable with the DVDD. Patient satisfaction was especially related to the major reduction in transportation time (7 h). Reductions in traveling costs and saved working days were the most important factors in making the telemedicine set-up economically efficient.
Telemedicine consultation for remote outpatient diabetes control is feasible, and the interdisciplinary interventions achieved high treatment quality results in essential diabetes treatment parameters. In addition, the telemedicine set-up was associated with improved cost-effectiveness and patient satisfaction.
糖尿病患者数量的不断增加给医疗保健系统带来了重大挑战。应对这些挑战的一种手段可能是使用远程医疗,同时这也可能降低治疗成本。自2005年以来,法尔岛的糖尿病患者一直通过远程会诊获得专家糖尿病护理。本文描述了远程医疗解决方案对糖尿病基本治疗参数、患者满意度和成本效益的影响。
在法尔岛医院的会诊室里,患者和护士专家与位于大陆医院的医生进行视听联系,开展远程医疗会诊。会诊由电子病历和基于网络的糖尿病质量监测数据库提供支持。
这项回顾性研究的纳入标准是至少6个月的远程医疗糖尿病控制,最少两次就诊和两个糖化血红蛋白(HbA1c)值。结果与丹麦国家糖尿病登记处(DVDD)的数据进行比较。数据以中位数给出。总共纳入了23例1型糖尿病(T1DM)患者,年龄65岁(56 - 74岁)对比48岁,糖尿病病程21.0年(10.7 - 31.3年)对比20.5年,以及55例2型糖尿病(T2DM)患者,年龄67岁(64 - 70岁)对比65岁,糖尿病病程14.0年(10.5 - 17.5年)对比11.7年。远程会诊后,T1DM患者的HbA1c为8.0%(7.4 - 8.6%)对比7.9% [64(57 - 71)对比63 mmol/mol],无显著差异,T2DM患者的HbA1c为7.4%(7.1 - 7.7%)对比7.6% [57(54 - 61)对比60 mmol/mol],p < 0.05。体重指数、血压和血脂值与DVDD的数据相当。患者满意度尤其与交通时间大幅减少(7小时)有关。差旅成本的降低和工作日的节省是使远程医疗设置在经济上具有效率的最重要因素。
远程门诊糖尿病控制的远程医疗会诊是可行的,跨学科干预在糖尿病基本治疗参数方面取得了较高的治疗质量结果。此外,远程医疗设置与成本效益的提高和患者满意度相关。